NCT00769379 2025-06-12
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
Phase 3 Completed
Clinical Trials
9 trialsNCT02636582 2023-12-05
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT03323658 2023-01-10
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01849250 2021-12-28
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Phase 2 Completed
NCT00555152 2018-04-20
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
National Cancer Institute (NCI)
Phase NA Completed
NCT01052740 2017-07-02
X-Ray Mammography Standard of Care Protocol
National Institutes of Health Clinical Center (CC)
Completed
NCT00637481 2016-12-29
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00602628 2013-06-26
Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast
National Cancer Institute (NCI)
Phase NA Completed
NCT00245024 2013-05-03
Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed